Print Page   |   Contact Us   |   Sign In   |   Join
Business Wire Life Sciences News (FL)
Share |

Mazor Robotics to Present at the Piper Jaffray Healthcare ConferenceOpen in a New Window

CAESAREA, Israel--(BUSINESS WIRE)--Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a pioneer and a leader in the field of robotic guidance systems announced today that Sharon Levita, Chief Financial Officer & Vice President, Business Operations, is scheduled to present an overview of the Company, via a fireside chat discussion, at the Piper Jaffray Healthcare Conference on Tuesday, November 28, 2017 at 3:00pm ET at the Lotte New York Palace in New York City. A live audio webcast and subse

 

Pharmacy Times Continuing Education™ to Host Pharmacists Reaching Out®: Improving Treatment and Care in Patients with Lung CancerOpen in a New Window

CRANBURY, N.J.--(BUSINESS WIRE)--Pharmacy Times Continuing Education™ to Host Pharmacists Reaching Out®: Improving Treatment and Care in Patients with Lung Cancer

 

Foley Survey Shows Surging Telemedicine Services Across the Health Care Spectrum, into Foreign MarketsOpen in a New Window

TAMPA, Fla.--(BUSINESS WIRE)--Foley & Lardner LLP surveyed health care executives and providers on the business and legal issues impacting the advancement of telemedicine.

 

Bovie Medical Corporation to Participate in Upcoming Investor ConferencesOpen in a New Window

CLEARWATER, Fla.--(BUSINESS WIRE)--Bovie Medical Corporation (BVX), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today announced that management will participate in the following investor conferences in November: The 8th Annual Craig-Hallum Alpha Select Conference at the Sheraton New York Times Square Hotel in New York, New York. Management will present on Thursday, November 16 at 10:00 a.m. Eastern Time. The Piper Jaffray 29th Annual

 

PotNetwork Subsidiary Diamond CBD to Exhibit at the 6th Annual Las Vegas MJBizCon EventOpen in a New Window

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--PotNetwork Holding, Inc. (OTC Pink: POTN) announced today that the Company’s subsidiary, Diamond CBD, is exhibiting at the 6th Annual MJBizCon event. This trade show attracts not only the largest, but the most-qualified buying audience of any cannabis event in America. The MJBizCon Expo is home to over 650 vendors, and expects attendees to exceed 14,000. This semi-annual, all-professional event has earned a reputation of being “the event where deals get d

 

TransEnterix Announces Senhance US Sale Agreement With Florida HospitalOpen in a New Window

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that Florida Hospital entered into an agreement to purchase the Company’s Senhance™ Surgical Robotic System. The Florida Hospital Orlando campus will be home to the first commercial unit of the Senhance Surgical System to be installed in the United States. Now available in the United States

 

Oragenics, Inc. Regains Compliance with NYSE American Continued Listing StandardsOpen in a New Window

TAMPA, Fla.--(BUSINESS WIRE)--Oragenics Inc Regains Compliance NYSE American Continued Listing Standards

 

eCTD Submissions of IND and NDA/BLA to the US FDA, EU and Canada: 2-Day Workshop by Ex-FDA Official (Orlando, FL, United States - February 1-2, 2018) - Research and MarketsOpen in a New Window

DUBLIN--(BUSINESS WIRE)--The "eCTD Submissions of IND and NDA/BLA to the US FDA, EU and Canada: 2-Day Workshop by Ex-FDA Official" conference has been added to Research and Markets' offering. The international agreement to assemble all Quality, Safety and Efficacy information for a drug or biologic product into a common format (called the CTD - Common Technical Document) has improved the speed and efficiency for companies working in global development programs and clarified expectations by regu

 

Alpha Source, Inc.® Recognized for Outstanding Corporate GrowthOpen in a New Window

MILWAUKEE--(BUSINESS WIRE)--Alpha Source, Inc. announced today it was the recipient of the Outstanding Corporate Growth Award.

 

LENSAR® Receives FDA Clearance for IntelliAxis™-L - LENSAR Laser System’s Novel Toric Intraocular Lens Alignment GuidanceOpen in a New Window

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR® receives US FDA clearance and E.U. CE Mark for IntelliAxis™-L, the LENSAR Laser System's novel toric IOL alignment guidance.

 

Bio-Tissue Announces First Study to Demonstrate Corneal Nerve Regeneration in Patients with Dry Eye Disease with the Use of PROKERAOpen in a New Window

MIAMI--(BUSINESS WIRE)--Bio-Tissue, Inc., a business unit of TissueTech, Inc., announced today the publication of “Corneal Nerve Regeneration after Self-Retained Cryopreserved Amniotic Membrane in Dry Eye Disease” in The Journal of Ophthalmology, 2017 (John, et al.), the first study to show that cryopreserved amniotic membrane is correlated with corneal nerve regeneration in patients with dry eye disease (DED). The study results will be presented at the upcoming American Academy of Ophthalmolog

 

Oragenics Announces Closing of $3.3 Million Preferred Stock Private Placement and $3.4 Million Debt Conversion into EquityOpen in a New Window

TAMPA,Fla.--(BUSINESS WIRE)--Oragenics Announces Closing of $3.3 Million Preferred Stock Private Placement and $3.4 Million Debt Conversion into Equity

 

The Lions Eye Institute for Transplant & Research Launches One World Sight Alliance to Help Eradicate Preventable Blindness Throughout the WorldOpen in a New Window

TAMPA, Fla.--(BUSINESS WIRE)--#blindness--The Lions Eye Institute for Transplant & Research launches One World Sight Alliance to help eradicate preventable blindness throughout the world.

 

Ophthalmic Industry Leader William J. Link, Ph.D., Joins LENSAR, Inc. Board of Directors as ChairmanOpen in a New Window

ORLANDO, Fla.--(BUSINESS WIRE)--William J. Link, Ph.D. joins LENSAR, Inc. board of directors as chairman.

 

Wall Street Veterans Join Singular Medical Technologies Board of DirectorsOpen in a New Window

WINTER HAVEN, Fla.--(BUSINESS WIRE)--#imaging--Singular Medical Technologies (SMT), an emerging technology company initially focused on high-performance hardware and software solutions in health care for Picture Archiving Communications Systems (“PACS”) for hospitals, imaging centers, radiology, teleradiology and cardiology groups, announced today that two Wall Street veterans have joined the company’s board of directors. They are John Adair, former Head of Equities for Nomura and Richard A. Brown, Jr.,

 

CERENIS Therapeutics Acquires LYPRO Biosciences Expanding Its HDL Strategy Into Immuno-Oncology and Chemotherapeutic Drug DeliveryOpen in a New Window

TOULOUSE, France & LAKELAND, Fla.--(BUSINESS WIRE)--Regulatory News: CERENIS Therapeutics (FR0012616852 – CEREN – PEA PME eligible) (Paris:CEREN) an international biopharmaceutical company dedicated to the discovery and development of HDL-based innovative therapies for treating cardiovascular and metabolic diseases, today announces the acquisition of LYPRO Biosciences assets, a portfolio of proprietary drug delivery nanotechnology. The operation positions CERENIS at the forefront of the chemoth

 

TherapeuticsMD to Present at Two Upcoming Investor ConferencesOpen in a New Window

BOCA RATON, Fla.--(BUSINESS WIRE)--TXMD to present at Stifel 2017 Healthcare Conference on November 14 and the Jefferies 2017 London Healthcare Conference on November 15-16

 

Noven Files Patent Infringement Lawsuit against AlvogenOpen in a New Window

MIAMI & JERSEY CITY, N.J.--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc. announced today that it has filed a lawsuit in the U.S. District Court of Delaware against Alvogen, Inc. and Alvogen Pine Brook, LLC. (collectively, “Alvogen”) for patent infringement. Alvogen is seeking approval to market and sell a generic version of Minivelle® (estradiol transdermal system) prior to the expiration of two of Noven’s Orange Book listed patents (U.S. Patent Nos. 9724310 and 9730900). The lawsuit reflects No

 

Mazor Robotics Reports Record Third Quarter 2017; Revenue More Than Doubles to $17.2 MillionOpen in a New Window

CAESAREA, Israel--(BUSINESS WIRE)--Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a pioneer and a leader in the field of robotic guidance systems, reported record third quarter revenue of $17.2 million. As previously announced, the Company received purchase orders for 22 systems in the 2017 third quarter, including 19 Mazor X systems. Recent Significant Highlights Entered the next phase of its strategic partnership with Medtronic assuming exclusive worldwide distribution of the Mazor X syste

 

Opdivo (nivolumab) Demonstrates Superior Three-Year Survival Benefit for Patients with Previously Treated Advanced Renal Cell Carcinoma (RCC)Open in a New Window

PRINCETON, N.J.--(BUSINESS WIRE)--$BMY #BMS--Opdivo (nivolumab) Demonstrates Superior Three-Year Survival Benefit for Patients with Previously Treated Advanced Renal Cell Carcinoma (RCC)

 

TherapeuticsMD Announces Third Quarter 2017 Financial ResultsOpen in a New Window

BOCA RATON, Fla.--(BUSINESS WIRE)--TXMD releases business and financial results for third quarter 2017

 

Tower MSA Partners’ Dan Anders and Swissport’s Beth Savelli will present “Old Dogs, New Settlement Tricks” at National Workers’ Compensation & Disability ConferenceOpen in a New Window

LAS VEGAS--(BUSINESS WIRE)--Tower MSA Partners' Dan Anders & Swissport's Beth Savelli to share an aggressive strategy for closing legacy workers comp claims at NWCDC.

 

TherapeuticsMD Announces Plan to Resubmit the New Drug Application for TX-004HROpen in a New Window

BOCA RATON, Fla.--(BUSINESS WIRE)--After meeting with FDA on Nov. 3, TXMD to Resubmit the New Drug Application for TX-004HR

 

AVEO Oncology and EUSA Pharma Announce Promising Phase 1 Results from the Phase 1/2 TiNivo Study of Tivozanib and Nivolumab in Renal Cell CarcinomaOpen in a New Window

CAMBRIDGE, Mass. & HEMEL HEMPSTEAD, England--(BUSINESS WIRE)--AVEO Oncology (NASDAQ:AVEO) and EUSA Pharma today announced the presentation of promising results from the ongoing Phase 1 portion of the TiNivo study, a Phase 1/2 multicenter trial of tivozanib (FOTIVDA®) in combination with Bristol-Myers Squibb’s nivolumab (OPDIVO®), an immune checkpoint, or PD-1, inhibitor, for the treatment of advanced renal cell carcinoma (RCC). The results were presented on Friday, November 3, at the 16th Inter

 

AVEO Oncology and EUSA Pharma Announce Promising Phase 1 Results from the Phase 1/2 TiNivo Study of Tivozanib and Nivolumab in Renal Cell CarcinomaOpen in a New Window

CAMBRIDGE, Mass. & HEMEL HEMPSTEAD, England--(BUSINESS WIRE)--AVEO Oncology (NASDAQ:AVEO) and EUSA Pharma today announced the presentation of promising results from the ongoing Phase 1 portion of the TiNivo study, a Phase 1/2 multicenter trial of tivozanib (FOTIVDA®) in combination with Bristol-Myers Squibb’s nivolumab (OPDIVO®), an immune checkpoint, or PD-1, inhibitor, for the treatment of advanced renal cell carcinoma (RCC). The results were presented on Friday, November 3, at the 16th Inter

 

TherapeuticsMD to Host TX-004HR Regulatory Update and Third Quarter Financial Results Conference Call and Webcast on November 6Open in a New Window

BOCA RATON, Fla.--(BUSINESS WIRE)--TXMD to host conf call on Nov 6 at 8am to discuss regulatory update and Q3 financial results

 

New AHF Billboard Campaign Highlights Troubling Global HIV/AIDS Statistics As World AIDS Day Approaches on December 1stOpen in a New Window

LOS ANGELES--(BUSINESS WIRE)--#AHF--AHF launches new outdoor advertising campaign to call attention to the millions of people still affected by HIV/AIDS around the globe today.

 

Bovie Medical Corporation Reports Third Quarter 2017 Financial Results and Updates Fiscal Year 2017 Financial OutlookOpen in a New Window

CLEARWATER, Fla.--(BUSINESS WIRE)--Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today reported financial results for its third fiscal quarter ended September 30, 2017. Third Quarter 2017 Financial Summary: Advanced Energy revenue of $2.1 million, up 52% year-over-year, driven by strong J-Plasma® sales. Advanced Energy revenue increased 17% quarter-over-quarter in Q3. Core revenue

 

RepScrubs Signs Agreement with Premier to Help More Hospitals Prevent InfectionsOpen in a New Window

ORLANDO, Fla.--(BUSINESS WIRE)--RepScrubs® has signed an agreement with Premier, a healthcare improvement company with one of the nation’s largest healthcare group purchasing organizations (GPOs), to provide more hospitals with one-time-use, recyclable surgical scrubs for the thousands of surgical equipment sales representatives who visit operating rooms every day. Under the agreement, a direct sourcing subsidiary of Premier Inc., S2S Global, will begin manufacturing an exclusive line of RepScr

 

RTI Surgical® Announces 2017 Third Quarter ResultsOpen in a New Window

ALACHUA, Fla.--(BUSINESS WIRE)--RTI Surgical® Announces 2017 Third Quarter Results

 

Oncology Analytics Appoints Rick Dean as Chief Executive OfficerOpen in a New Window

PLANTATION, Fla.--(BUSINESS WIRE)--#CEO--Rick Dean Appointed as Chief Executive Officer of Oncology Analytics

 

Exactech Announces Successful First Revision Knee Replacement Surgery with Truliant® InstrumentationOpen in a New Window

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, is pleased to announce that the first revision knee surgery was performed using the company's award-winning Truliant® instrumentation. Orthopaedic surgeons will have a chance to experience the Truliant primary and revision systems through live mechanical demonstrations Nov. 2-5 at the American Association of Hip and Kn

 

HemWell America Reports 2.6% of All Patients Who Think They Have Hemorrhoids Have CancerOpen in a New Window

TAMPA, Fla.--(BUSINESS WIRE)--HemWell America, Inc. (HemWell) www.hemwellamerica.com, an urgent care anal-rectal outpatient clinic company, focusing on hemorrhoid care and other anal-rectal issues, reported today that 2.6% off all patients seen at a HemWell location this year (2017) were found to have cancer. Over one-third (34%) of all cancers found were in patients aged 45-54, the report found. In addition men represented 78% of all patients found with cancer. The report uses a sample of 1,23

 

Aurora Diagnostics Announces the Acquisition of the CytoPath Pathology Practice in AlabamaOpen in a New Window

PALM BEACH GARDENS, Fla.--(BUSINESS WIRE)--Aurora Diagnostics, a leading independent pathology services and cancer diagnostics company, today announced the acquisition of CytoPath, bringing to 30 the number of affiliated local pathology practices around the country. Based just south of Birmingham in Alabaster, Ala., CytoPath is a physician-owned medical practice providing surgical pathology and cytopathology services to eight hospitals and five referring physician group clients in Central and S

 

AltemiaTM Achieves Successful Clinical Results in Pediatric Patients with Sickle Cell Disease (SCD)Open in a New Window

RIVIERA BEACH, Fla.--(BUSINESS WIRE)--#ALT--Sancilio Pharmaceuticals Company, Inc. (SPCI) today announced positive top line results from a clinical study evaluating the efficacy and safety of AltemiaTM, an oral soft gelatin dosage form, in pediatric sickle cell patients aged 5-17 years (https://clinicaltrials.gov/ct2/show/NCT02973360). Sickle cell disease is characterized by an imbalance of certain fatty acids in blood cell membranes resulting in an increase in blood cell adhesion, chronic inflammati

 

Long Island Woman Meets Lifesaving Donor at Gift of Life Marrow Registry 5kOpen in a New Window

BOCA RATON, Fla.--(BUSINESS WIRE)--#giftoflife--A Long Island bone marrow transplant recipient met her lifesaving donor at the Gift of Life Marrow Registry 5k held on Oct. 30, 2017 in NYC.

 

Physicians’ Education Resource® to Present at the 2018 Alliance for Continuing Education in the Health Professions Annual ConferenceOpen in a New Window

CRANBURY, N.J.--(BUSINESS WIRE)--Physicians’ Education Resource® to Present at the 2018 Alliance for Continuing Education in the Health Professions Annual Conference

 

Tracey Burgess Joins Windham Group as Regional Sales ExecutiveOpen in a New Window

ST. CLOUD, Fla.--(BUSINESS WIRE)--Tracey Burgess has joined Windham Group as regional sales executive. Burgess' territory is the state of Florida.

 

Exactech Q3 Revenue $61.4 MillionOpen in a New Window

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that revenue for the third quarter of 2017 increased 2% to $61.4 million from $59.9 million in the third quarter of 2016, and 2% on a constant currency basis. Domestic revenue increased 2% to $43.3 million, and international revenue increased 2% to $18.1 million in the third quarter of 2017. Dilut

 

Concordia Care, Inc. Applauds Declaration of Opioid Crisis as a Public Health EmergencyOpen in a New Window

MIAMI--(BUSINESS WIRE)--#opioidcrisis--Concordia Care, Inc. Applauds Declaration of Opioid Crisis as a Public Health Emergency

 

Sancilio Pharmaceuticals Company, Inc. to Present an Update on Research in Sickle Cell at Upcoming National SCDAA ConventionOpen in a New Window

RIVIERA BEACH, Fla.--(BUSINESS WIRE)--#ALT--Sancilio Pharmaceuticals Company, Inc. (SPCI) will present an update on the research program in the field of sickle cell disease, at the National Sickle Cell Disease Association of America (SCDAA) convention, being held in Atlanta from October 25-28, 2017. SPCI is developing Altemia™ as a treatment for pediatric patients with sickle cell disease. The Company previously announced enrollment completion of the clinical trial, highlighting high retention rates

 

AMNIOX Medical Introduces RESPINA™ at NASS 2017Open in a New Window

ORLANDO, Fla.--(BUSINESS WIRE)--AMNIOX Medical, Inc., a TissueTech, Inc. company, highlighted the introduction of RESPINA its cryopreserved umbilical cord/amniotic membrane matrix at the North American Spine Society’s (NASS) annual meeting in Orlando, FL, October 25 - 27. AMNIOX Medical’s proprietary amniotic membrane technology has been clinically proven in a randomized controlled trial to enhance surgical outcomes in microdiscectomy, improving function and reducing both pain and the incidence

 

Exactech Cancels Q3 Earnings Call Previously Scheduled for Tuesday, October 31, 2017Open in a New Window

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that, due to its definitive agreement with TPG Capital to go private, the company will not hold the Third Quarter conference call previously scheduled for Tuesday, October 31, 2017. Exactech will report the results for the third quarter with a press release following the market close on Monday, Oc

 

RTI Surgical® Launches Fortilink®-C IBF System, the First 3D Printed Polymer-based Interbody DeviceOpen in a New Window

ALACHUA, Fla.--(BUSINESS WIRE)--RTI Surgical® Launches Fortilink®-C IBF System, the First 3D Printed Polymer-based Interbody Device

 

First Prospective Study of Robotic-Guided Spine Surgery Reveals Five-Fold Reduction in Surgical Complications with Mazor Core™ TechnologyOpen in a New Window

ORLANDO, Fla.--(BUSINESS WIRE)--At the North American Spine Society (NASS) Annual Meeting, a group including 10 investigators are presenting interim results from the first multi-center prospective study of robotic-guided spine surgery. The results demonstrate that spinal surgeries performed using Mazor Robotics’ (TASE: MZOR; NASDAQ GM: MZOR) Renaissance Guidance System, powered by the proprietary Mazor Core™ technology, have a five-fold reduction in surgical complications and a seven-fold reduc

 

Biogennix Ramps Up National Distribution for Bone Graft Substitute Products osteoSPAN and MorpheusOpen in a New Window

IRVINE, Calif.--(BUSINESS WIRE)--Biogennix has announced it is expanding distribution on a national level for its bone graft substitute products.

 

CellRight Technologies to Participate in World’s Largest Spine ExhibitionOpen in a New Window

SAN ANTONIO, Texas--(BUSINESS WIRE)--Tissue Regenix Group plc (AIM:TRX) (‘Tissue Regenix’ or ‘The Group’) the UK based regenerative medical devices company announces subsidiary CellRight Technologies (‘CellRight’) will be participating in The North American Spine Society annual meeting - NASS 2017, being held in Orlando, Florida, October 25-28 2017. NASS is the largest spine exhibition in the world where spine care professionals from around the globe will share the latest information on new tec

 

Largest Provider of Senior Healthcare in Southeast, Miami Jewish Health Systems, Selects Aerohive for Wireless Healthcare SolutionOpen in a New Window

MILPITAS, Calif.--(BUSINESS WIRE)--#Aerohive--Aerohive Networks® (NYSE: HIVE), a Cloud Networking leader, today announced that Miami Jewish Health Systems selected Aerohive to run complex wireless healthcare solutions across its numerous medical facilities and research laboratories. Miami Jewish Health was founded in Miami, Florida in 1940 and serves more than 12,000 patients across more than a dozen facilities, offering programs in rehabilitation, medical care and research, and residential living facilit

 

Spineology to Highlight Novel Lateral Interbody Fusion System at NASSOpen in a New Window

ST. PAUL, Minn.--(BUSINESS WIRE)--Spineology highlighting FDA-cleared Duo™ Lumbar Interbody Fusion System at the NASS annual meeting in Orlando at booth #913.

 

Minneamrita Announces FDA Clearance of Investigational New Drug (IND) Application and Initiation of a Phase I Clinical Trial of an Oral Formulation of Minnelide in Patients with Advanced CancerOpen in a New Window

TAMPA, Fla.--(BUSINESS WIRE)--Minneamrita today announced that an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 1 trial of an oral formulation of the company's Minnelide for patients with advanced cancers is now active. The first patient to participate in this exciting clinical trial received treatment this past week at HonorHealth Research Institute. Dr. Erkut Borazanci, the Principal Investigator at HonorHealth Research Institute, states

 

Life Spine Announces Initial Cases and Multiple Surgeries with the SENTRY® ALIF Plating SystemOpen in a New Window

HUNTLEY, Ill.--(BUSINESS WIRE)--Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today the initial cases and multiple surgeries performed with SENTRY ALIF Plating System. “I have been a user of PRESIDIO®, Life Spine’s predicate ALIF plating system, for around a decade and have been very pleased with the system. The built-in CAM locking mechanism featured in the new SENTRY ALIF Plate further s

 

Stryker’s Spine Division to Commercially Launch Serrato Pedicle Screw at NASS 2017Open in a New Window

ALLENDALE, N.J.--(BUSINESS WIRE)--Stryker Spine today announced that it will commercially launch its Serrato™ pedicle screw at NASS 2017, Oct. 25–28 in Orlando, Fla. (booth No. 500).

 

Sites Medical Licenses its OsteoSync™ Ti Technology to Integrity Implants for Incorporation into their FlareHawk™ Family of Expandable ImplantsOpen in a New Window

COLUMBIA CITY, Ind.--(BUSINESS WIRE)--Sites Medical, a firm specializing in value-driven innovation in orthopedics, today announced it has entered into a licensing agreement with Integrity Implants, to incorporate its proprietary OsteoSync™ Ti technology into Integrity’s novel multi-dimensional expandable interbody devices. “We are thrilled to be partnering with Integrity Implants, a company with a high degree of innovation in the spine field and an accomplished leadership team,” said Greg Stal

 

Liberty Health Sciences Inc. Signs Licensing and Raw Materials Agreement with Mary’s Medicinals to Provide Floridians with Range of Award-Winning Cannabis ProductsOpen in a New Window

TORONTO--(BUSINESS WIRE)--#alternativemedicine--Liberty Health Sciences signs licensing and raw materials agreement with Mary’s Medicinals to provide Floridians with award-winning cannabis products

 

Mazor Robotics to Report Third Quarter Financial Results on November 7, 2017Open in a New Window

CAESAREA, Israel--(BUSINESS WIRE)--Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a pioneer and a leader in the field of surgical robotic guidance systems, announced today that it will report financial results for the third quarter ended September 30, 2017, before the U.S. markets open on Tuesday, November 7, 2017. The company will host a conference call to discuss these results on Tuesday, November 7, 2017, at 8:30 AM ET (3:30 PM IST). Investors within the United States interested in partic

 

Stryker’s Spine Division to Launch Tritanium® C Anterior Cervical Cage at NASS 2017Open in a New Window

ALLENDALE, N.J.--(BUSINESS WIRE)--Stryker Spine will introduce its Tritanium C Anterior Cervical Cage at the NASS 2017 Annual Meeting, Oct. 25–28, in Orlando, Fla. (booth No. 500)

 

Exactech Enters Definitive Agreement with TPG Capital to Go PrivateOpen in a New Window

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech (Nasdaq: EXAC), a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, today announced that it has entered into a definitive merger agreement under which TPG Capital, the global private equity platform of alternative asset firm TPG, will acquire all of the outstanding shares of Exactech common stock. Exactech’s board of directors approved the agreement which provides for the paym

 

Pilgrim Quality Solutions to Address Pharmaceutical Implications of CDER Metrics and ReportingOpen in a New Window

TAMPA, Fla.--(BUSINESS WIRE)--Pilgrim Quality Solutions, a leading global provider of enterprise quality management software and services for the Life Sciences, today announced it will present a live webcast later this month for pharmaceutical organizations on the implications of participating in the Food and Drug Administration’s (FDA) Quality Metrics reporting program. The webinar, Solutions for CDER Metrics and Reporting, on October 31, 2017, will be co-presented by Cynthia Lambert, Regulato

 

Health Mart and APCI Celebrate Pharmacists on Florida Independent Pharmacy DayOpen in a New Window

LAKELAND, Fla.--(BUSINESS WIRE)--Health Mart® and APCI Celebrate Pharmacists on Florida Independent Pharmacy Day

 

RTI Surgical® Introduces TETRAfuse® 3D Technology Becoming First to Offer 3D Printed Interbody Polymer Optimized to Participate in FusionOpen in a New Window

ALACHUA, Fla.--(BUSINESS WIRE)--RTI Surgical® Introduces TETRAfuse® 3D Technology Becoming First to Offer 3D Printed Interbody Polymer Optimized to Participate in Fusion

 

Spineology Initiates Post-Market Lateral Interbody Fusion Study Using Novel Implant DesignOpen in a New Window

ST. PAUL, Minn.--(BUSINESS WIRE)--Spineology initiating prospective, post-market lateral interbody fusion study designed to evaluate patient outcomes using its FDA-cleared Duo.

 

OncLive® to Host First Regional Seminar Series in MiamiOpen in a New Window

CRANBURY, N.J.--(BUSINESS WIRE)--OncLive® to Host First Regional Seminar Series in Miami on Oct. 26

 

BayCare Health System Welcomes Publix Retail PharmaciesOpen in a New Window

LAKELAND, Fla.--(BUSINESS WIRE)--With the opening of in-hospital Publix pharmacies at BayCare, the first piece of an exclusive, three-part collaboration between Publix and BayCare Health System is in place. Publix retail pharmacies are now open at St. Anthony’s Hospital’s Suncoast Medical Clinic in St. Petersburg, St. Joseph’s Hospital in Tampa and at Morton Plant Hospital’s new Doyle Tower in Clearwater. Publix pharmacies are also planned to open at Mease Countryside Hospital in Safety Harbor

 

Bio-Tissue Announces Strategic Agreement with Optima Pharmazeutische GmbH to Distribute its Natural Ocular Cleanser in GermanyOpen in a New Window

MIAMI & MUNICH/HALLBERGMOOS, Germany--(BUSINESS WIRE)--Bio-Tissue, Inc., a business unit of TissueTech, Inc., is pleased to announce a strategic agreement with Optima Pharmazeutische GmbH, a leading distributor of ophthalmic products for the treatment of dry eye, blepharitis and meibomian gland dysfunction (MGD) in Germany and Austria. The agreement supports efforts to bring Bio-Tissue’s natural ocular cleanser formulated with 4-Terpineol, Cliradex®, to the German eye care professionals market.

 

Fabric Genomics Partners to Improve Pediatric CareOpen in a New Window

ORLANDO, Fla.--(BUSINESS WIRE)--#ICU--Fabric Genomics has partnered with Genomics England’s 100,000 Genomes Project, Rady Children’s Institute for Genomic Medicine (RCIGM), and The Utah Genome Project (UGP), to provide fast and accurate identification of pediatric disease-causing variants to improve the clinical care of children. Fabric Genomics’ Opal™ Clinical is the only genomic interpretation and reporting platform to include the algorithms VAAST and Phevor, two pioneering algorithms for genomic d

 

10x Genomics Enables High-Volume Studies by Providing More Affordable Solutions for Whole Genome and Exome AnalysisOpen in a New Window

PLEASANTON, Calif.--(BUSINESS WIRE)--#ASHG17--10x Genomics Enables High-Volume Studies by Providing More Affordable Solutions for Whole Genome and Exome Analysis.

 

10x Genomics Announces the Addition of Unbiased Gene Expression and B-cell Repertoire to the Chromium Single Cell V(D)J SolutionOpen in a New Window

PLEASANTON, Calif.--(BUSINESS WIRE)--#ASHG17--10x Genomics announces the addition of unbiased gene expression and B-cell repertoire to the Chromium Single Cell V(D)J Solution.

 

Dassault Systèmes’ Living Heart Project Reaches Next Milestones in Mission to Improve Patient CareOpen in a New Window

HOLLYWOOD, Fla.--(BUSINESS WIRE)--Dassault Systèmes (Paris:DSY) (Euronext Paris: #13065, DSY.PA) today outlined, at the 3DEXPERIENCE Forum North America, multiple milestones in its Living Heart Project aimed to drive the creation and use of simulated 3D personalized hearts in the treatment, diagnosis and prevention of heart diseases. As the scientific and medical community seeks faster and more targeted ways to improve patient care, the Living Heart Project is extending its reach through new pa

 

Intermountain Healthcare Announces Precision Health Research Endeavors with 10x GenomicsOpen in a New Window

PLEASANTON, Calif. & ST. GEORGE, Utah--(BUSINESS WIRE)--#ASHG17--Intermountain Healthcare Announces Precision Health Research Endeavors with 10x Genomics

 

Bovie Medical Corporation to Release Third Quarter 2017 Financial Results on November 2, 2017Open in a New Window

CLEARWATER, Fla.--(BUSINESS WIRE)--Bovie Medical (NYSE American: BVX), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today announced that financial results for the third quarter of 2017 will be released after the market closes on Thursday, November 2. Management will host a conference call at 4:30 p.m. Eastern Time on November 2 to discuss the results of the quarter and host a question and answer session. To listen to the call by phone,

 

Life Spine to Showcase Micro Invasive Expandable Technology at NASS Annual MeetingOpen in a New Window

HUNTLEY, Ill.--(BUSINESS WIRE)--Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it will be participating in the 32nd North American Spine Society (NASS) Annual Meeting, taking place in Orlando, October 24-27th, 2017. The meeting is expected to attract over 3,000 surgeons and other healthcare professionals from across the globe. Life Spine is excited to showcase its Procedural Solu

 

Health Mart® Showcases Solutions for Clinical and Financial Performance at NCPAOpen in a New Window

ORLANDO, Fla.--(BUSINESS WIRE)--Health Mart® Showcases Solutions for Clinical and Financial Performance at NCPA

 

Agilent Expands SureGuide Portfolio with CRISPR-based Products to Accelerate Disease ResearchOpen in a New Window

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the first expansion of the SureGuide pooled CRISPR libraries for functional genomics, offering pooled libraries for CRISPR activation and interference (CRISPR a/i). The announcement was made at the at the American Society for Human Genetics Conference (ASHG), being held October 17 - 21 in Orlando, Florida. Every SureGuide CRISPR library is synthesized using Agilent’s advanced SurePrint DNA synthesis platfo

 

Adventist Health System Partners with Glytec to Enhance Diabetes CareOpen in a New Window

WALTHAM, Mass.--(BUSINESS WIRE)--#A1C--Adventist Health System, headquartered in Altamonte Springs, Florida, will implement Glytec’s diabetes therapy management software at 39 hospitals.

 

Precision Medicine Meets Single-Cell DNA Analysis With Mission BioOpen in a New Window

ORLANDO, Fla. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--#AML--Mission Bio has secured $10 million in Series A funding and launched a precision genomics platform called Tapestri to move precision medicine forward

 

Convey Health Solutions Acquires Gorman Health GroupOpen in a New Window

FORT LAUDERDALE, Fla. & WASHINGTON--(BUSINESS WIRE)--#SaaS--Convey Health Solutions announced the acquisition of Gorman Health Group.

 

McKesson RxOwnership Expands Support of Independent Pharmacy OwnershipOpen in a New Window

ORLANDO, Fla.--(BUSINESS WIRE)--McKesson RxOwnership® Expands Support of Independent Pharmacy Ownership

 

Advanzeon Solutions, Inc. Retains Philip C. Pulver as Communications Director and Chief Consultant for Contract NegotiationsOpen in a New Window

TAMPA, Fla.--(BUSINESS WIRE)--Advanzeon Solutions retains Philip C. Pulver as Communications Director and Chief Consultant for Contract Negotiations

 

Pilgrim Quality Solutions & The Knowledge Group to Wrap Up Risk Management Webinar Series for the Pharmaceutical IndustryOpen in a New Window

TAMPA, Fla.--(BUSINESS WIRE)--Pilgrim Quality Solutions, a leading global provider of enterprise quality management software and services for the Life Sciences, today announced the final presentation in a panel format series hosted by The Knowledge Group, on current risk- and compliance-centric trends impacting quality processes within the Pharmaceutical industry. The series concludes November 8, 2017, at 12:00 pm, with a live telecast, Practical Tips in Managing Supplier Risks in the Life Scie

 

Concordia Care, Inc. Participates in eServices’ Risk Management Summit Addressing Challenges Related to the Opioid Epidemic and Injured WorkersOpen in a New Window

MIAMI--(BUSINESS WIRE)--#RMSummit2017--Concordia Care, Inc. participates in eServices’ Risk Management Summit to address challenges related to the opioid epidemic and injured workers.

 

Results from Phase 2 Studies of Oral Ozanimod in Crohn’s Disease and Ulcerative Colitis to Be Presented at World Congress of Gastroenterology at ACG2017Open in a New Window

SUMMIT, N.J.--(BUSINESS WIRE)--#Crohns--Celgene Corporation (NASDAQ:CELG) today announced that phase 2 data of investigational compound ozanimod in Crohn’s disease and ulcerative colitis will be presented at the World Congress of Gastroenterology at ACG2017 (WCOG at ACG2017) in Orlando. The studies include new data from the STEPSTONE study in patients with moderately to severely active Crohn’s disease (CD) and long-term data from the open-label extension of the TOUCHSTONE study in patients with moderate

 

Ambry Presents Scientific Discovery to Enhance Clinical Practice at American Society for Human Genetics Annual Meeting (ASHG)Open in a New Window

ALISO VIEJO, Calif. & ORLANDO, Fla.--(BUSINESS WIRE)--Ambry Genetics Corporation (Ambry), a leading genetic testing lab, will be participating at the American Society of Human Genetics Annual Meeting (ASHG). Ambry’s 16 posters and 6 oral presentations cover the entire spectrum of research including many of the challenges currently facing the genetics community. One of the main challenges for genetic testing labs is determining which reported mutations can be translated into meaningful data to a

 

Ironwood Pharmaceuticals Presenting Linaclotide Data at the World Congress of Gastroenterology at ACG 2017Open in a New Window

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals today announced that the company and its collaborators are presenting clinical data for linaclotide at WCOG at ACG 2017.

 

AZOVA, Inc. Announces Launch of Digital Vaccination Management SystemOpen in a New Window

ALPINE, Utah--(BUSINESS WIRE)--#NCPA--AZOVA launches a digital Vaccination Management System to reduce over-vaccinations and under vaccinations and allows for vaccination self-management.

 

New Clinical Data Using the NvisionVLE® Imaging System to Be Presented at the World Congress of Gastroenterology @ ACG 2017 and UEGW 2017Open in a New Window

BEDFORD, Mass.--(BUSINESS WIRE)--NinePoint Medical, Inc., a transformative medical device company pioneering the use of an advanced imaging platform for gastrointestinal applications, today announced that new clinical data relating to its proprietary NvisionVLE® Imaging System with Real-time Targeting™ will be presented at two upcoming major conferences. Seven clinical abstracts will be featured at the World Congress of Gastroenterology @ the ACG 2017 conference taking place October 13-18 in Or

 

Compulink Showcases Best-of-Breed Technology for Gastroenterologists at ACG2017Open in a New Window

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Compulink Showcases Best-of-Breed Technology for Gastroenterologists at ACG2017. MACRA-ready all-in-one solution includes unique OneTab™ EHR.

 

Aries Pharmaceuticals and Olympus Initiate Co-Promotion of Eleview™ at the American College of Gastroenterology’s World CongressOpen in a New Window

SAN DIEGO--(BUSINESS WIRE)--Aries Pharmaceuticals, Inc. (Aries), a specialty pharmaceutical company commercializing best-in-class gastroenterology products utilized in endoscopy and for the treatment of select gastrointestinal diseases, today announced it will initiate with Olympus the co-promotion of Eleview™ at the American College of Gastroenterology’s (ACG) World Congress in Orlando, Fla. Eleview is an FDA 510(k) cleared, ready-to-use submucosal injection composition that provides an immedi

 

Exactech Comments on Impact of Hurricanes Irma and Harvey; Adjusts Q3 Earnings Guidance and Announces Q3 Earnings CallOpen in a New Window

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, said today it is adjusting guidance for the third quarter of 2017 as a result of the impact of Hurricanes Irma and Harvey. CEO and President David Petty said the estimated US revenue impact of the two hurricanes was approximately $1.2M to sales in Q3 across Florida, Texas, Georgia and the Carolinas. “We were fort

 

Synergy Pharmaceuticals to Highlight New Data for TRULANCE® (Plecanatide) at the World Congress of Gastroenterology (WCOG) at American College of Gastroenterology (ACG)Open in a New Window

NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals to Highlight New Data for TRULANCE® (plecanatide) at ACG 2017

 

PER®’s Miami Breast Cancer Conference®’s Program Chair Dr. Patrick I. Borgen to Be Featured on Sirius XM Doctor RadioOpen in a New Window

CRANBURY, N.J.--(BUSINESS WIRE)--PER®’s Miami Breast Cancer Conference®’s Program Chair Dr. Patrick I. Borgen to Be Featured on Sirius XM Doctor Radio

 

Generex Announces Exclusive Distribution Contract For Rapid 1-2-3® Hema HIV EXPRESS® in ChileOpen in a New Window

MIRAMAR, Fla.--(BUSINESS WIRE)--Generex Announces Exclusive Distribution Contract For Rapid 1-2-3® Hema HIV EXPRESS® in Chile

 

10x Genomics Announces Automated Workflow for Dried Blood Spot and Saliva for Linked-Read Sequencing.Open in a New Window

PLEASANTON, Calif.--(BUSINESS WIRE)--10x Genomics announces automated workflow for Dried Blood Spot and Saliva for Linked-Read Sequencing.

 

Liberty Health Sciences Inc. and Resolve Digital Health Inc. Strike Exclusive Partnership to Provide Floridians with Innovative Cannabis Metered-Dosing Inhalation SolutionsOpen in a New Window

TORONTO--(BUSINESS WIRE)--#alternativemedicine--Liberty Health Sciences partners with Resolve Digital Health to introduce industry-leading smart medical cannabis inhalation products in FL

 

AmpliPhi Biosciences to Participate in Two Upcoming ConferencesOpen in a New Window

SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation today announced that management will present a company overview at two upcoming investor conferences.

 

Physicians’ Education Resource® Announces the Miami Breast Cancer Conference®: Attendee Tumor BoardOpen in a New Window

CRANBURY, N.J.--(BUSINESS WIRE)--Physicians’ Education Resource® Announces the Miami Breast Cancer Conference®: Attendee Tumor Board

 

Asuragen to Present at 2017 American Society of Human Genetics (ASHG) ConferenceOpen in a New Window

AUSTIN, Texas--(BUSINESS WIRE)--Asuragen, Inc., a molecular diagnostics products company changing the way patients are treated in genetics and oncology by bringing complex molecular tests to hospital and reference labs, will present two posters and participate in a workshop panel sponsored by Thermo Fisher Scientific at the upcoming American Society of Human Genetics (ASHG) Conference on October 17-21 in Orlando, Florida. “Our focus at ASHG this year is on our growing product pipeline for neuro

 

PAVmed to Present at Dawson James Securities 3rd Annual Small Cap Growth ConferenceOpen in a New Window

NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly differentiated, multi-product medical device company, today announced that Dennis McGrath, PAVmed’s Chief Financial Officer, will present at the Dawson James Securities 3rd Annual Small Cap Growth Conference on Thursday, October 19, 2017 at 1:00 p.m. Eastern time. Mr. McGrath will provide a corporate overview, discuss the Company’s innovative business model and review PAVmed’s lead products. The conference will be held at the

 

Pilgrim to Share Critical ISO 13485:2016 Audit Tips in Live WebinarOpen in a New Window

TAMPA, FLa.--(BUSINESS WIRE)--Pilgrim Quality Solutions, a leading global provider of enterprise quality management software and services for the Life Sciences, today announced it will present a live webcast this week on how medical device organizations can prepare their Quality team and their Quality Management System (QMS) for a successful ISO 13485:2016 assessment. This will be the fourth in a 4-part series presented by Pilgrim on the newest version of the ISO 13485 regulation. The webinar,

 

Mazor Robotics Received 22 System Orders During Q3 2017; Expects to Report Record Quarterly RevenueOpen in a New Window

CAESAREA, Israel--(BUSINESS WIRE)--Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a pioneer and a leader in the field of surgical robotic systems, expects to report record revenue of approximately $17.2 million for the third quarter ended September 30, 2017. During the third quarter of 2017, the Company received a total of 22 system purchase orders from customers in the U.S., Asia and Israel. The 22 orders are comprised of: 19 purchase orders for the Mazor X™ system, of which 11 were ordered

 

150 Community Oncology Providers & Patient Support Teams Explore the Future of Immuno-Oncology at ION Solutions’ I-O ConferenceOpen in a New Window

ORLANDO, Fla.--(BUSINESS WIRE)--Today, ION Solutions, a part of AmerisourceBergen and the largest physician service organization and group purchasing organization (GPO) specializing in the support of community oncology, commenced its inaugural Immuno-Oncology (I-O) Conference. As part of ION and AmerisourceBergen’s commitment to providing critical resources that will ultimately enhance patient care, the conference brings together more than 150 community oncology physicians, nurses, pharmacists

 

Abbott

BioFlorida, Inc. | 6742 Forest Hill Blvd., Suite 256 | West Palm Beach, FL 33413
(P) 561-653-3839 admin@bioflorida.com
Membership Management Software Powered by YourMembership  ::  Legal